Thousands of people with obesity in England will be able to get a new weight loss drug on the NHS after a watchdog approved its use. Patients on the weekly injections have seen their weight fall by an average of 12% after one year, the National Institute for Health and Care Excellence (Nice) said. It has issued draft guidance recommending semaglutide, also known as Wegovy, for adults with at...